四川多瑞药业
2025-05-22
US FDA Registration No.: 041446Indication: Acromegaly, GEP-NETs, Carcinoid Syndrome
Batch Size:6 kg
Annual Capacity:150 kg
Status: Validation Production Complete
Prev:
Next: